Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

C20orf134 Inhibitors

ctin-like 10, often abbreviated as ACTL10 or ACTL6B, is a member of the actin family of proteins and shares considerable sequence homology with conventional actin. Despite this similarity, ACTL10 possesses unique features that distinguish it from the globular and filamentous forms of actin typically involved in cytoskeletal structure and cell motility.ACTL10 is particularly known for its role in chromatin remodeling as a component of the BAF (BRG1/BRM-associated factor) complex, which is pivotal for the regulation of gene expression by altering the chromatin structure, thereby controlling the accessibility of transcription factors to DNA. It functions as a scaffold in the BAF complex, providing structural support for the assembly of other subunits and enabling the complex to exert its effects on chromatin architecture.

The protein is widely expressed in various tissues and is essential for several developmental processes. Studies have shown that mutations or alterations in the ACTL10 gene can have significant implications for human health, including associations with neurodevelopmental disorders and possibly impacting oncogenic processes.As a chromatin remodeling factor, ACTL10 plays a critical part in the epigenetic regulation of gene expression. It does not directly bind to DNA but influences DNA accessibility indirectly through its action within the BAF complex. The dynamic remodeling of chromatin by ACTL10-containing complexes facilitates essential cellular processes such as differentiation, proliferation, and response to DNA damage.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Paclitaxel stabilizes microtubules and prevents their disassembly, indirectly affecting actin dynamics by altering the microtubule-actin filament crosstalk.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

This compound disrupts actin polymerization, potentially altering the cellular processes where ACTL10 is involved due to changes in actin network dynamics.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Latrunculin A binds to actin monomers, preventing their polymerization, which could indirectly affect ACTL10 activity by modulating the actin cytoskeleton.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

It stabilizes actin filaments and prevents their depolymerization, potentially influencing ACTL10 activity through altered actin dynamics.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

A ROCK inhibitor, Y-27632 can alter actin cytoskeleton dynamics by inhibiting Rho-associated kinase, possibly affecting ACTL10-related processes.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

This inhibitor of myosin II can indirectly influence ACTL10 by altering myosin-actin interactions, impacting actin filament organization and dynamics.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$91.00
$267.00
13
(1)

ML-7 inhibits myosin light chain kinase, affecting actin-myosin interactions and potentially influencing processes involving ACTL10.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$321.00
$1040.00
5
(0)

By inhibiting the Arp2/3 complex, CK-666 indirectly affects actin polymerization, potentially impacting ACTL10-related cellular activities.

NVP-BHG712

940310-85-0sc-364554
sc-364554A
5 mg
50 mg
$232.00
$1764.00
(0)

This inhibitor of formin homology 2 domains disrupts actin nucleation and elongation, potentially affecting ACTL10's functional context within cells.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

As a PI3K inhibitor, Wortmannin may indirectly influence ACTL10 activity by altering downstream signaling pathways that affect actin dynamics.